Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older [Phase 3]
Phase 3 study evaluating safety and efficacy of once-daily ciclesonide HFA for perennial allergic rhinitis in individuals 12 years and older…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber [Phase 2]
Phase 2 trial comparing GSK256066 to placebo in allergic rhinitis patients using a pollen challenge chamber has completed.
-
FDA approval · 2012-05-31FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved the original application for azelastine hydrochloride, a generic product from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: House Dust Mite SLIT in Elderly Patients [Phase 4]
A Phase 4 clinical trial evaluating house dust mite sublingual immunotherapy for elderly patients with allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) [Phase 3]
Phase 3 trial in adult and adolescent subjects with perennial allergic rhinitis completed; results were posted in May 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis [Phase 3]
Phase 3 long-term safety and efficacy trial of Beclomethasone Dipropionate HFA 320 mcg for allergic rhinitis completed with results posted i…
-
FDA approval · 2012-05-22FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Children's Zyrtec (cetirizine hydrochloride) by Kenvue Brands LLC.
-
FDA approval · 2012-05-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.)
The FDA approved the original ANDA for cetirizine hydrochloride (oral solution) from Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals La…
-
FDA approval · 2012-05-01FDA Approved: DYMISTA — Original Application (Viatris Specialty LLC)
FDA approved DYMISTA (azelastine hydrochloride and fluticasone propionate) under an Original Application by Viatris Specialty LLC, introduci…
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS [Phase 2]
This clinical trial update notes the completion of a Phase 2 pilot study evaluating the efficacy and safety of WF10 for persistent allergic …
-
CLINICAL_TRIALS research · 2012-04-23Clinical Trial Update: The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study
This clinical trial update examines factors associated with nasal polyp formation using case-control and descriptive methods.
-
FDA approval · 2012-04-19FDA Approved: DESLORATADINE — Original Application (Virtus Pharmaceuticals, LLC)
The FDA approved Virtus Pharmaceuticals, LLC’s generic desloratadine via an Original Application (ANDA). This adds a generic option for desl…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)
A completed clinical trial evaluating desloratadine syrup in Filipino children to observe side effects and effectiveness for allergic rhinit…
-
FDA approval · 2012-02-23FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) submitted by Chattem, Inc., approving the change…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol [Phase 1]
Phase 1 study assessing pharmacokinetics and safety of beclomethasone dipropionate HFA nasal aerosol in allergic rhinitis has completed.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo [Phase 4]
A Phase 4 clinical trial evaluating onset of action of fluticasone furoate nasal spray and olopatadine nasal spray versus placebo for allerg…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: PURETHAL Grasses Rush Study [Phase 4]
Phase 4 trial update for HAL Allergy's PURETHAL Grasses Rush immunotherapy in allergic rhinitis and allergic rhinoconjunctivitis; the study …
-
FDA approval · 2012-02-10FDA Approved: DESLORATADINE — Original Application (Natco Pharma USA LLC)
FDA approved an original application for a desloratadine generic from Natco Pharma USA LLC.
-
FDA approval · 2012-02-06FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (AMERISOURCE BERGEN)
FDA approved an original application for fexofenadine hydrochloride (a generic antihistamine) with Amerisource Bergen. The product is indica…
-
FDA approval · 2012-02-03FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
-
FDA approval · 2012-02-03FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion, a combination product of fexofenadine hydrochloride and pseudo…
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: Sublingual Immunotherapy in Children With Allergic Rhinitis [NA]
The document reports the completion of a clinical trial evaluating sublingual immunotherapy for children with allergic rhinitis.
-
FDA approval · 2012-01-09FDA Approved: FLUTICASONE PROPIONATE SPRAY, METERED — Original Application (Chartwell RX, LLC)
The FDA approved the original application for Fluticasone Propionate Spray, Metered, a generic nasal spray (fluticasone propionate) submitte…
-
FDA approval · 2011-12-21FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Original Application (Haleon US Holdings LLC)
FDA approved the original application for Advil Allergy and Congestion Relief, a combination product containing chlorpheniramine maleate, ib…
-
FDA approval · 2011-12-16FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC, resulting in an update to the product labeling via a sup…